Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahmoud Aljurf

Showing results (361-370 of 403) with videos related to

Pageof 41
Sort By:
Hematology/Oncology and Stem Cell Therapy|June 20, 2025
Acute and chronic graft-versus-host disease treatment and management in the Eastern Mediterranean region: A Worldwide Network for Blood and Marrow Transplantation surveyIbrahim N Muhsen, Dietger Niederwieser, Laurent Garderet, et al.
Blood Advances|April 25, 2024
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minoritiesNandita Khera, Sikander Ailawadhi, Ruta Brazauskas, et al.
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyZachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Blood|July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Pageof 41

Showing results (361-370 of 403) with videos related to

Sort By:
Pageof 41
Hematology/Oncology and Stem Cell Therapy|June 20, 2025
Acute and chronic graft-versus-host disease treatment and management in the Eastern Mediterranean region: A Worldwide Network for Blood and Marrow Transplantation surveyIbrahim N Muhsen, Dietger Niederwieser, Laurent Garderet, et al.
Blood Advances|April 25, 2024
Trends in volumes and survival after hematopoietic cell transplantation in racial/ethnic minoritiesNandita Khera, Sikander Ailawadhi, Ruta Brazauskas, et al.
Haematologica|April 21, 2022
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysisMatthew Mei, Raju Pillai, Soyoung Kim, et al.
Bone Marrow Transplantation|December 12, 2018
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Blood Advances|October 2, 2020
Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDSVikas Gupta, Soyoung Kim, Zhen-Huan Hu, et al.
Bone Marrow Transplantation|February 28, 2019
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMTYoshihiro Inamoto, Igor Petriček, Linda Burns, et al.
Ejhaem|May 29, 2025
Efficacy of Total-Body Irradiation-based Intensified Myeloablative Regimens for Acute Leukemia-An International Collaborative StudyYasuyuki Arai, Ruta Brazauskas, Naya He, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 1, 2019
Maintenance Tyrosine Kinase Inhibitors Following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia: A Center for International Blood and Marrow Transplant Research StudyZachariah DeFilipp, Richard Ancheta, Ying Liu, et al.
Leukemia & Lymphoma|July 15, 2020
Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patientsBei Hu, Xiao Lin, Hans C Lee, et al.
Blood|July 5, 2017
Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United StatesLori Muffly, Marcelo C Pasquini, Michael Martens, et al.
Pageof 41